• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND ENDURANT II ILIAC STENT GRAFT; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND ENDURANT II ILIAC STENT GRAFT; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Model Number ETLW1620C124E
Medical Device Problem Codes Difficult to Remove (1528); Material Deformation (2976)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 08/08/2024
Type of Reportable Event Malfunction
Event or Problem Description
An endurant ii stent graft etlw1620c124e limb was implanted during the endovascular treatment of a 40mm aaa.It was reported that during the index procedure, after deployment of the stent graft the trigger on the delivery system would not move and was jammed.The physician was unable to join the grey slider to the blue trigger handle.The physician was able to remove the delivery system without patient injury despite this.It was confirmed the deployment itself went fine.Per the physician the cause of the removal difficulty could not be determined.No additional clinical sequalae were provided and the patient is fine.
 
Additional Manufacturer Narrative
Film evaluation summary: the reported "difficult to remove" of the endurant iliac delivery system could not be assessed on the pre-implant films provided, therefore a cause can not be established.Lack of provision of procedural images showing the deployment of the stent graft and removal of the delivery system means that the reported removal difficulties event cannot be assessed.An unknown procedural or possible device issue cannot be ruled out as a potential cause.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Additional Manufacturer Narrative
Product analysis device returned with the external slider in the open position.An excessive kink was visible on the graft cover distal to strain relief due to folding of the device to return.The external slider was rotated, and the graft cover was retracted and advanced with no resistance noted.Resistance was noted retracting the trigger.The trigger did not return to the home position when released after activation.There was no damage evident to the screw gear threads which would have hindered movement of the slider.The external slider was disassembled.The trigger sleeve did not return to the home position.The end of the spring was trapped between the trigger sleeve and the inner slider.Longitudinal scratches were visible on the inner sider.On removal of the spring from between the sleeve and inner slider no resistance was noted retracting and advancing the trigger.The reported removal difficulties were confirmed through analysis.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Additional Manufacturer Narrative
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENDURANT II ILIAC STENT GRAFT
Common Device Name
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
EI 
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
EI  
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
EI  
091708096
MDR Report Key20125061
Report Number9612164-2024-04022
Device Sequence Number7462719
Product Code MIH
UDI-Device Identifier00643169467552
UDI-Public00643169467552
Combination Product (Y/N)N
Initial Reporter StateLA
Initial Reporter CountryUS
PMA/510(K) Number
P100021
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2024
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date (Section B) 12/18/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date05/01/2026
Device Model NumberETLW1620C124E
Device Catalogue NumberETLW1620C124E
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/09/2024
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 08/08/2024
Supplement Date Received by Manufacturer10/25/2024
12/18/2024
Initial Report FDA Received Date09/03/2024
Supplement Report FDA Received Date11/15/2024
12/18/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured05/01/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient Age64 YR
Patient SexMale
-
-